<DOC>
	<DOC>NCT01859481</DOC>
	<brief_summary>Evaluation of headache response at 2 hours for active treated attacks for increasing dose.</brief_summary>
	<brief_title>Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Migraine without Aura</mesh_term>
	<mesh_term>Migraine with Aura</mesh_term>
	<mesh_term>Eletriptan</mesh_term>
	<criteria>Male and Female subjects in good general health, aged 18 to 65 years. Subjects should meet IHS diagnostic criteria for migraine with or without aura. Based on past history, subjects should expect to suffer at least one acute attack of migraine with or without aura, each 6 weeks Known coronaryartery disease, clinically significant arrhythmia, heart failure, or uncontrolled hypertension. Pregnant or lactating women. Clinically significant electrocardiogram abnormalities at screening.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>